Amgen By Your Side is a support program for patients prescribed TEPEZZA. Our dedicated team is your patient’s partner, committed to providing nonmedical support to help patients as they start and continue on treatment as you prescribe.
Amgen By Your Side is a support program for patients prescribed TEPEZZA® (teprotumumab-trbw)
Coverage across commercial and government insurance types1
*Based on commercial plans analyzed. Individual patient access varies.
Enrolling in Amgen By Your Side provides your patients a dedicated support committed to providing nonmedical support as they start and continue on treatment
Dedicated Patient Access Liaisons (PAL)
Every patient is paired with a PAL who provides one-on-one support—from education on benefits investigation to treatment coordination.
Infusion and access support
PALs help educate patients on site-of-care options, insurance, and financial support to help patients access their treatment as prescribed.
Treatment logistics support
Patients receive ongoing education and appointment reminders to help them stay on track with treatment goals.
TED Team Peer-to-Peer Program
Connects prescribed patients with peers who’ve completed TEPEZZA treatment to share real-world experience and offer encouragement.
My PAL was amazing. She would join calls with me and help me advocate. You have different people telling you different information, and when it would get complex my PAL would step in.
– Lily Z., Real TEPEZZA patient
(compensated for her time)
Once you decide TEPEZZA is right for your patient, you can initiate their enrollment in Amgen By Your Side
Explore everything Amgen By Your Side offers to your appropriate patients
Paying for treatment shouldn’t get in the way of health
Amgen Commercial Co-Pay Program
Eligible patients with commercial insurance may pay as little as $0† out-of-pocket for the cost of the medication and the infusion administration through the Amgen Commercial Co-Pay Program.
Terms and Conditions:
Offer cannot be combined with any other rebate or coupon, free trial, or similar offer for the specified prescription. Not valid for prescriptions reimbursed in whole or in part by any government-funded program including but not limited to Medicare, Medicare Part D, Medicaid, Medigap, VA, CHAMPUS, DOD, TRICARE, or any state, patient foundation, or other pharmaceutical program. Offer good only in the United States at participating specialty pharmacies or sites of care. Offer not valid where otherwise prohibited by law, for example by applicable state law prohibiting co-pay cards. Amgen reserves the right to rescind, revoke, or amend offer without notice. The selling, purchasing, trading, or counterfeiting of any co-pay card or benefits is prohibited by law. This co-pay program is not insurance and is not intended to substitute for insurance. Age for eligibility is dependent on product indication.
‡Please note that independent foundations establish, administer, and implement the funds, which are separate and apart from Amgen. While we cannot guarantee access or reimbursement for our medicines, we can educate you and your staff about gaining access to the medicine and various patient financial support programs.
The Amgen Commercial Co-pay Program may be available to patients who meet the following minimum criteria:
- Patient’s prescription cannot be paid in part or in full by any government-funded program including but not limited to: Medicare, Medicare Part D, Medicaid, Medigap, VA, CHAMPUS, Department of Defense (DOD), TRICARE, or any state, patient foundation, or other pharmaceutical program
- Patient is prescribed a covered Amgen rare disease medication for an indication approved by the Food and Drug Administration; the indication for each product is shown in its prescribing information
- Patient is a resident of the United States
- Patient must be commercially insured and have financial responsibility for a portion of the drug and/or infusion cost if applicable
The assistance offered under this co-pay program is subject to additional terms and conditions, including but not limited to the following:
Terms and Conditions: Offer cannot be combined with any other rebate or coupon, free trial, or similar offer for the specified prescription. Not valid for prescriptions reimbursed in whole or in part by any government-funded program including but not limited to: Medicare, Medicare Part D, Medicaid, Medigap, VA, CHAMPUS, DOD, TRICARE, or any state, patient foundation, or other pharmaceutical program. Offer good only in the United States at participating specialty pharmacies or sites of care. Offer not valid where otherwise prohibited by law, for example by applicable state law prohibiting co-pay cards. Amgen reserves the right to rescind, revoke, or amend offer without notice. The selling, purchasing, trading, or counterfeiting of any co-pay card or benefits is prohibited by law. This co-pay program is not insurance and is not intended to substitute for insurance. Age for eligibility is dependent on product indication.
Participating Pharmacies or Healthcare Providers: By using this co-pay program, you acknowledge and confirm that the prescription will not be reimbursed in whole or in part by any government-funded program (such as, without limitation, Medicare, Medicaid, VA, DOD, TRICARE) and the patient and prescription meet the eligibility criteria set forth in the terms and conditions. You are responsible for reporting the receipt of the co-pay program benefits as required by an insurer, payor, or applicable law or regulation.
Patients: By enrolling in this co-pay program, you acknowledge and confirm that you and the prescription meet the eligibility requirements set forth in the terms and conditions, including that the prescription will not be reimbursed in whole or in part by any government-funded program (such as, without limitation, Medicare, Medicaid, VA, DOD, TRICARE). You may not seek any claims to government payors or other payors or insurers for this prescription. You may not seek reimbursement from any health savings, flexible savings, or other healthcare reimbursement account for any amounts received from the co-pay program. You are responsible for reporting the receipt of the co-pay program benefits as required by an insurer, payor, or applicable law or regulation.